Colgate-Palmoliv

how big is Colgate-Palmoliv?

As of Jun 06, Colgate-Palmolive (India) Ltd has a market capitalization of 66,262.50 Cr and reported Net Sales of 5999.20 Cr and a Net Profit of 1436.81 Cr for the latest four quarters.

Market Cap: <BR>As of Jun 06, Colgate-Palmolive (India) Ltd has a market capitalization of 66,262.50 Cr, categorizing it as a Large Cap company.<BR><BR>Recent Quarterly Performance: <BR>For the latest 4 quarters, the company reported Net Sales of 5999.20 Cr and a Net Profit of 1436.81 Cr. This data is based on Standalone financials.<BR><BR>Balance Sheet Snapshot: <BR>The Balance Sheet data is Consolidated and pertains to the latest annual period of Mar'10. Shareholder's Funds are reported at 330.22 Cr, while Total Assets amount to 867.10 Cr.

Who are in the management team of Colgate-Palmoliv?

As of March 2022, Colgate-Palmolive's management team includes V S Mehta, Indu Shahani, Shyamala Gopinath, M S Jacob, Mukul Deoras, Sukanya Kripalu, Sekhar Natarajan, GOPIKA PANT, Surender Sharma, PRABHA NARASIMHAN, and Indu Bhushan, featuring a mix of independent and executive directors.

As of March 2022, the management team of Colgate-Palmolive includes the following individuals:<BR><BR>1. V S Mehta - Independent Director<BR>2. Indu Shahani - Independent Director<BR>3. Shyamala Gopinath - Independent Director<BR>4. M S Jacob - Whole Time Director & CFO<BR>5. Mukul Deoras - Chairman (Non-Executive)<BR>6. Sukanya Kripalu - Independent Director<BR>7. Sekhar Natarajan - Independent Director<BR>8. GOPIKA PANT - Independent Director<BR>9. Surender Sharma - Whole-time Director & CS<BR>10. PRABHA NARASIMHAN - Managing Director & CEO<BR>11. Indu Bhushan - Additional Director<BR><BR>This team comprises a mix of independent directors, executive directors, and non-executive leadership, reflecting a diverse governance structure.

What does Colgate-Palmoliv do?

Colgate-Palmolive (India) Limited is a leading FMCG company specializing in oral care products, with a recent net sales of ₹1,452 Cr and a net profit of ₹355 Cr as of March 2025. It operates as a subsidiary of Colgate-Palmolive, USA, and has a market capitalization of ₹66,265 Cr.

Overview: <BR>Colgate-Palmolive (India) Limited is a leading provider of scientifically proven oral care products in the FMCG sector, classified as a large-cap company.<BR><BR>History: <BR>Colgate-Palmolive (India) Ltd is a subsidiary of Colgate-Palmolive, USA. The company has been operational for several years, with the latest quarterly results reported for March 2025, showcasing its ongoing presence in the market.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 1,452 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 355 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: Rs 66,265 Cr (Large Cap)<BR><BR>Key Metrics: <BR>P/E: 46.00 <BR>Industry P/E: 54 <BR>Dividend Yield: 0.98% <BR>Debt-Equity: -0.62 <BR>Return on Equity: 86.32% <BR>Price to Book: 40.07<BR><BR>Contact Details: <BR>Address: Colgate Research Ctr Main St, Hiranandani Gardens Powai Mumbai Maharashtra : 400076 <BR>Tel: 91-022-67095050 <BR>Email: investor_grievance@colpal.com <BR>Website: http://www.colgatepalmolive.co.in

What is the bonus history of the Colgate-Palmoliv?

Colgate-Palmolive (India) Ltd's most recent bonus issue was a 1:1 bonus announced on September 23, 2015, with a record date of September 24, 2015, allowing shareholders to receive an additional share for each share owned.

Colgate-Palmolive (India) Ltd has a notable bonus history, with its latest bonus issue being a 1:1 bonus announced on September 23, 2015. The record date for this bonus was September 24, 2015. This means that shareholders received an additional share for every share they owned at that time. If you have any more questions about the company or its financials, feel free to ask!

Who are the peers of the Colgate-Palmoliv?

Colgate-Palmoliv's peers include Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, P&G Hygiene, Godfrey Phillips, Gillette India, and Emami. Most peers exhibit excellent management risk and capital structure, with varying growth rates and returns, where Godfrey Phillips leads in 1-year return at 123.46% and Colgate-Palmoliv shows a -7.80% return.

Peers: The peers of Colgate-Palmoliv are Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, P&G Hygiene, Godfrey Phillips, Gillette India, and Emami.<BR><BR>Quality Snapshot: Excellent management risk is observed at ITC, Nestle India, Britannia Inds., P&G Hygiene, Gillette India, and Emami, while Good management risk is found at Hind. Unilever and Godrej Consumer, and the rest. Below Average growth is noted for Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Colgate-Palmoliv, P&G Hygiene, and Emami, while Average growth is found at Nestle India, and the rest. All peers have Excellent capital structure except Hatsun Agro, which has Average capital structure.<BR><BR>Return Snapshot: Godfrey Phillips has the highest 1-year return at 123.46%, while P&G Hygiene has the lowest at -16.16%. Colgate-Palmoliv’s 1-year return is -7.80%, which is higher than P&G Hygiene's but lower than Godfrey Phillips'. Additionally, the six-month return is negative for Colgate-Palmoliv, P&G Hygiene, and Emami.

Is Colgate-Palmoliv overvalued or undervalued?

As of April 12, 2023, Colgate-Palmolive is considered very expensive with a PE ratio of 46.11 and has underperformed the Sensex with a year-to-date return of -9.04%, indicating it may be overvalued at its current price of 2439.40.

As of 12 April 2023, the valuation grade for Colgate-Palmolive has moved from expensive to very expensive, indicating a significant increase in perceived overvaluation. The company is currently assessed as overvalued, with a PE ratio of 46.11, a price to book value of 39.80, and an EV to EBITDA ratio of 33.30. These ratios suggest that the stock is trading at a premium compared to its earnings and book value.<BR><BR>In comparison to its peers, Colgate-Palmolive's valuation metrics are notably high, with Hindustan Unilever at a PE of 53.88 and Nestle India at a staggering PE of 75.2, both classified as very expensive. Despite being in a competitive landscape, Colgate-Palmolive's ratios indicate it is priced higher than many of its industry counterparts. The company's stock has underperformed relative to the Sensex, with a year-to-date return of -9.04% compared to the Sensex's 5.59%, reinforcing the notion that it may be overvalued at its current price of 2439.40.

Who are the top shareholders of the Colgate-Palmoliv?

The top shareholders of Colgate-Palmolive include the company itself with 40.06%, foreign institutional investors at 22.22%, mutual funds with 4.69%, individual investors holding 16.56%, and the Life Insurance Corporation of India as the largest public shareholder at 1.68%. There are no pledged promoter holdings.

The top shareholders of Colgate-Palmolive include the Colgate-Palmolive Company, which holds the largest stake at 40.06%. Other significant shareholders are foreign institutional investors (FIIs), who collectively own 22.22%, and mutual funds, which are held by 34 schemes representing 4.69%. Additionally, individual investors hold 16.56% of the company, while the highest public shareholder is the Life Insurance Corporation of India, with a stake of 1.68%. There are no pledged promoter holdings, indicating a strong position among the promoters.

How has been the historical performance of Colgate-Palmoliv?

Colgate-Palmoliv demonstrated consistent growth from March 2007 to March 2010, with net sales increasing from 1,295.62 Cr to 1,962.46 Cr and profit after tax rising from 148.39 Cr to 434.10 Cr, reflecting improved operational efficiency and profitability. Key metrics such as EPS and cash flow also showed significant gains during this period.

Answer:<BR>The historical performance of Colgate-Palmoliv shows a consistent growth trend across various financial metrics from March 2007 to March 2010.<BR><BR>Breakdown:<BR>Colgate-Palmoliv's net sales increased from 1,295.62 Cr in March 2007 to 1,962.46 Cr in March 2010, reflecting a strong upward trajectory. Other operating income also rose, contributing to a total operating income that grew from 1,295.62 Cr in March 2007 to 2,032.90 Cr in March 2010. The total expenditure, excluding depreciation, increased from 1,145.55 Cr to 1,525.28 Cr during the same period, but the operating profit (PBDIT) saw a significant rise from 216.00 Cr to 532.55 Cr, indicating improved operational efficiency. Profit before tax followed a similar trend, climbing from 195.45 Cr to 500.39 Cr, while profit after tax surged from 148.39 Cr to 434.10 Cr. The earnings per share (EPS) also demonstrated substantial growth, increasing from 5.46 in March 2007 to 15.96 in March 2010. Operating profit margins improved from 11.58% to 24.97%, and the profit after tax margin increased from 11.45% to 21.43%, showcasing enhanced profitability. Cash flow from operating activities rose from 157.68 Cr to 403.99 Cr, contributing to a closing cash and cash equivalent balance that grew from 114.86 Cr to 347.67 Cr, indicating a solid liquidity position. Overall, Colgate-Palmoliv exhibited robust financial performance over the analyzed period.

Has Colgate-Palmoliv declared dividend?

Yes, Colgate-Palmolive (India) Ltd has declared a dividend of 2400% (₹24 per share) with an ex-date of November 3, 2025. Despite recent price volatility, total returns over the 2 to 5-year periods have shown positive trends.

Colgate-Palmolive (India) Ltd has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 2400%<BR>- Amount per share: 24<BR>- Ex-date: 03 Nov 25<BR><BR>Dividend Yield: 1.05%.<BR><BR>Total Returns by Period:<BR>In the 3-month period, the price return was -0.97%, the dividend return was 1.09%, resulting in a total return of 0.12%.<BR><BR>In the 6-month period, the price return was -18.0%, the dividend return was 0.89%, leading to a total return of -17.11%.<BR><BR>In the 1-year period, the price return was -30.77%, the dividend return was 1.55%, which resulted in a total return of -29.22%.<BR><BR>In the 2-year period, the price return was 7.81%, the dividend return was 4.54%, culminating in a total return of 12.35%.<BR><BR>In the 3-year period, the price return was 40.2%, the dividend return was 7.38%, resulting in a total return of 47.58%.<BR><BR>In the 4-year period, the price return was 43.03%, the dividend return was 10.23%, leading to a total return of 53.26%.<BR><BR>In the 5-year period, the price return was 52.64%, the dividend return was 12.86%, culminating in a total return of 65.5%.<BR><BR>Overall, Colgate-Palmolive (India) Ltd has declared a significant dividend, and while recent price returns have shown volatility, the total returns over longer periods indicate a positive trend, particularly in the 2 to 5-year ranges.

Is Colgate-Palmoliv technically bullish or bearish?

As of November 18, 2025, the market trend has shifted to bearish with moderate strength, driven by daily moving averages and monthly indicators, despite some mildly bullish signals on the weekly timeframe.

As of 18 November 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. Key indicators driving this include the daily moving averages indicating a bearish trend, the monthly MACD and Bollinger Bands both showing bearish signals, and the Dow Theory reflecting a mildly bearish outlook on both weekly and monthly time frames. Although the weekly MACD and KST are mildly bullish, they are overshadowed by the overall bearish sentiment in the longer-term indicators.

When is the next results date for Colgate-Palmolive (India) Ltd?

The next results date for Colgate-Palmolive (India) Ltd is January 29, 2026.

The next results date for Colgate-Palmolive (India) Ltd is scheduled for January 29, 2026.

Are Colgate-Palmolive (India) Ltd latest results good or bad?

Colgate-Palmolive (India) Ltd's latest results show a significant decline in net profit by 17.09% and net sales by 6.34% year-on-year, indicating ongoing challenges in the FMCG sector. Analysts have rated the stock as a "Strong Sell" due to concerns over the company's near-term recovery prospects.

Colgate-Palmolive (India) Ltd's latest results indicate a challenging period for the company. In Q3 FY26, the net profit was ₹327.51 crore, which represents a significant decline of 17.09% year-on-year. Similarly, net sales fell to ₹1,507.24 crore, down 6.34% from the previous year. Although there was a slight sequential improvement in sales compared to the previous quarter, the year-on-year contraction highlights ongoing structural issues.<BR><BR>The operating margin remained relatively stable at 30.88%, but this is a slight decrease from the previous year. The profit after tax margin also saw a notable decline, dropping to 21.73% from 24.55% a year earlier, reflecting operational pressures and a decrease in other income.<BR><BR>Overall, the results suggest that Colgate-Palmolive is facing significant challenges, particularly with volume growth and competitive pressures in the FMCG sector. The stock has also underperformed compared to the broader market, leading to a "Strong Sell" rating from analysts due to concerns about the company's near-term recovery prospects. Investors should be cautious, as the current financial trends indicate a negative outlook for the company.

Should I buy, sell or hold Colgate-Palmolive (India) Ltd?

Which are the latest news on Colgate-Palmoliv?

Why is Colgate-Palmolive (India) Ltd falling/rising?

As of 17-Feb, Colgate-Palmolive (India) Ltd's stock price is rising to 2,152.45, reflecting a 1.63% increase after a trend reversal. Despite this short-term gain, the stock has underperformed over the past year and faces challenges that may hinder its long-term growth prospects.

As of 17-Feb, Colgate-Palmolive (India) Ltd's stock price is rising, currently at 2,152.45, reflecting an increase of 34.55 (1.63%). This upward movement follows a trend reversal after four consecutive days of decline. The stock has outperformed its sector by 1.45% today and reached an intraday high of Rs 2160.2, indicating positive momentum.<BR><BR>Despite the recent rise, the stock has shown mixed performance over various periods. Over the past week, it has decreased by 1.49%, but it has gained 2.39% over the last month and 3.70% year-to-date. However, it has significantly underperformed over the past year, with a decline of 12.70% compared to a 9.81% increase in the Sensex.<BR><BR>Factors contributing to the stock's rise today include its higher performance relative to the sector and a strong management efficiency reflected in a high return on equity (ROE) of 73.11%. Additionally, the company maintains a low debt-to-equity ratio and has substantial institutional holdings at 28.97%, which may provide some stability and confidence among investors.<BR><BR>However, it is important to note that the stock's long-term growth prospects appear weak, with net sales growing at an annual rate of only 4.98% over the last five years. The recent negative financial results, including the lowest debtor turnover ratio and operating profit to net sales, raise concerns about its future performance. Overall, while the stock is currently rising, it faces significant challenges that could impact its trajectory moving forward.